METHYCLOTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyclothiazide patents expire, and what generic alternatives are available?
Methyclothiazide is a drug marketed by Chartwell Rx, Ivax Pharms, Mylan, Norvium Bioscience, Par Pharm, Usl Pharma, and Watson Labs. and is included in fifteen NDAs.
The generic ingredient in METHYCLOTHIAZIDE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYCLOTHIAZIDE?
- What are the global sales for METHYCLOTHIAZIDE?
- What is Average Wholesale Price for METHYCLOTHIAZIDE?
Summary for METHYCLOTHIAZIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,128 |
DailyMed Link: | METHYCLOTHIAZIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for METHYCLOTHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for METHYCLOTHIAZIDE
US Patents and Regulatory Information for METHYCLOTHIAZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089835-001 | Aug 18, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Pharm | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089135-001 | Feb 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ivax Pharms | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 087786-001 | May 18, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 085476-001 | Mar 11, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Pharm | METHYCLOTHIAZIDE | methyclothiazide | TABLET;ORAL | 089136-001 | Feb 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |